Philadelphia gene therapy startup plans $125M IPO

Another life sciences IPO for Greater Philadelphia: Gene therapy startup Passage Bio plans to go public via a $125 million IPO, to continue developing six gene therapy candidates for central nervous system diseases, including dementia.

Article from the Philadelphia Business Journal